Press release content from Accesswire. The AP news staff was not involved in its creation.
Abivax Publishes Review in Drug Discovery Today on Mechanism of Action and Transformative Potential of ABX464 as Therapy for Inflammatory Diseases
January 5, 2021 GMT
Scientific review summarizes the molecular events leading to potent anti-inflammatory effects of lead molecule ABX464, centered around the specific upregulation of microRNA-124 (miR-124)
Scientific data underpins ABX464′s potential to treat the root cause of inflammation explaining its efficacious induction and maintenance of clinical remission in Phase 2a ulcerative colitis clinical studies
The conclusions reinforce ABX464′s blockbuster potential across various inflammatory disease indications with high unmet medical needs